Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT
Jennifer Heimall(Children's Hospital of Philadelphia), Mort J. Cowan(University of California, San Francisco), Andrew R. Gennery(Hôpital Necker-Enfants Malades), Jennifer M. Puck(University of California, San Francisco), K. Scott Baker(Fred Hutch Cancer Center), Luigi D. Notarangelo(National Institutes of Health), Bénédicte Neven(Hôpital Necker-Enfants Malades), Mary Slatter(Great North Children's Hospital), Rebecca H. Buckley(Duke University), Andrew C. Dietz(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Thomas A. Fleisher(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Christine Duncan(Dana-Farber Cancer Institute), Élie Haddad(Centre Hospitalier Universitaire Sainte-Justine), Michael A. Pulsipher(Children's Hospital of Los Angeles)
Cited by 60
Related Papers
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
|Medicine|2000|1.7k
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k